Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPEP | Q07075 | 12/20 | 0.44 |
| ▸ | PRSS1 | P07477 | 4/20 | 0.35 |
| ▸ | TMPRSS15 | P98073 | 4/20 | 0.35 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24136500 | 1.00 | ENPEP (0.44) | ENPEPPRSS1TMPRSS15TGFBR1 | |
| SCHEMBL15027040 | 1.00 | ENPEP (0.44) | ENPEPPRSS1TMPRSS15TGFBR1 | |
| SCHEMBL23366202 | 1.00 | ENPEP (0.44) | ENPEPPRSS1TMPRSS15TGFBR1 | |
| SCHEMBL23366216 | 1.00 | ENPEP (0.44) | ENPEPPRSS1TMPRSS15TGFBR1 | |
| SCHEMBL23366231 | 1.00 | ENPEP (0.44) | ENPEPPRSS1TMPRSS15TGFBR1 | |
| SCHEMBL24136489 | 0.96 | ENPEP (0.46) | ENPEPPRSS1TMPRSS15TGFBR1 | |
| SCHEMBL7897829 | 0.83 | ACE (0.45) | ENPEP | |
| SCHEMBL23366206 | 0.82 | ENPEP (0.40) | ENPEPPRSS1TMPRSS15 | |
| SCHEMBL23366240 | 0.82 | ENPEP (0.40) | ENPEPPRSS1TMPRSS15 | |
| SCHEMBL23366203 | 0.82 | ENPEP (0.40) | ENPEPPRSS1TMPRSS15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11007274-B2 | Compounds for medicinal applications | AusVir Therapeutics Pty Ltd (AU) | 2021-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11007274-B2 | Compounds for medicinal applications | HAVCR2, ENGASE, DNPEP | ENPEP 69/4885PRSS1 459/4885TMPRSS15 44/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.